Stock Analysis
- Taiwan
- /
- Personal Products
- /
- TWSE:6666
Luo Lih-Fen Holding Second Quarter 2024 Earnings: EPS: NT$0.97 (vs NT$1.17 in 2Q 2023)
Luo Lih-Fen Holding (TWSE:6666) Second Quarter 2024 Results
Key Financial Results
- Revenue: NT$350.9m (up 13% from 2Q 2023).
- Net income: NT$46.1m (down 17% from 2Q 2023).
- Profit margin: 13% (down from 18% in 2Q 2023). The decrease in margin was driven by higher expenses.
- EPS: NT$0.97 (down from NT$1.17 in 2Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Luo Lih-Fen Holding shares are up 3.4% from a week ago.
Risk Analysis
It is worth noting though that we have found 3 warning signs for Luo Lih-Fen Holding (1 is potentially serious!) that you need to take into consideration.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About TWSE:6666
Luo Lih-Fen Holding
Researches and develops, manufactures, and sells cosmetics and medical devices in Taiwan and Mainland China.